Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Lung Cancer
About this trial
This is an interventional supportive care trial for Lung Cancer focused on measuring stage IIIB non-small cell lung cancer, stage IV non-small cell lung cancer, recurrent non-small cell lung cancer
Eligibility Criteria
Criteria:
- Diagnosis of stage IIIb-IV unresectable NSCLC
- Undergoing treatment with chemotherapy, radiation, or combined modalities
- Living within a 50 mile radius of the City of Hope
- No previous cancer within the past 5 years
Sites / Locations
- City of Hope Comprehensive Cancer Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Phase 2 Intervention
Phase I Usual Care
GROUP II (palliative care intervention): Patients receive an individualized interdisciplinary palliative care intervention comprising learner-centered, knowledge-centered, assessment-centered, and community-centered concepts. Patients undergo 4 teaching sessions, focused on physical, psychological, social, and spiritual well-being, once weekly in weeks 3-6. Patients then receive 4 follow-up phone calls in weeks 9, 13, 17, and 21.
GROUP I (usual care): Patients receive standard care.